Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Siderowf

Showing results (71-80 of 182) with videos related to

Pageof 19
Sort By:
Plos One|October 7, 2021
Biomarkers of neurodegeneration and glial activation validated in Alzheimer's disease assessed in longitudinal cerebrospinal fluid samples of Parkinson's diseaseMichael Bartl, Mohammed Dakna, Douglas Galasko, et al.
Dementia and Geriatric Cognitive Disorders|January 9, 2016
Effect of Amyloid Imaging on the Diagnosis and Management of Patients with Cognitive Decline: Impact of Appropriate Use CriteriaMichael Grundman, Keith A Johnson, Ming Lu, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 22, 2015
Cognition in individuals at risk for Parkinson's: Parkinson associated risk syndrome (PARS) study findingsLama M Chahine, Daniel Weintraub, Keith A Hawkins, et al.
Journal of the International Neuropsychological Society : JINS|May 25, 2012
Everyday action impairment in Parkinson's disease dementiaTania Giovannetti, Priscilla Britnell, Laura Brennan, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 25, 2017
Cognition and the course of prodromal Parkinson's diseaseDaniel Weintraub, Lana M Chahine, Keith A Hawkins, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 26, 2005
Differences in [99mTc]TRODAT-1 SPECT binding to dopamine transporters in patients with multiple system atrophy and Parkinson's diseaseRandel L Swanson, Andrew B Newberg, Paul D Acton, et al.
Journal of Alzheimer'S Disease : JAD|March 8, 2021
Relationships Between Cognition and Neuropathological Tau in Alzheimer's Disease Assessed by 18F Flortaucipir PETMichael D Devous, Adam S Fleisher, Michael J Pontecorvo, et al.
Brain and Cognition|January 6, 2012
Sentence processing in Lewy body spectrum disorder: the role of working memoryRachel G Gross, Corey T McMillan, Keerthi Chandrasekaran, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 2, 2006
Rasagiline improves quality of life in patients with early Parkinson's diseaseKevin M Biglan, Steven Schwid, Shirley Eberly, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 21, 2012
Neuropsychologic assessment in collaborative Parkinson's disease research: a proposal from the National Institute of Neurological Disorders and Stroke Morris K. Udall Centers of Excellence for Parkinson's Disease Research at the University of Pennsylvania and the University of WashingtonG Stennis Watson, Brenna A Cholerton, Rachel G Gross, et al.
Pageof 19

Showing results (71-80 of 182) with videos related to

Sort By:
Pageof 19
Plos One|October 7, 2021
Biomarkers of neurodegeneration and glial activation validated in Alzheimer's disease assessed in longitudinal cerebrospinal fluid samples of Parkinson's diseaseMichael Bartl, Mohammed Dakna, Douglas Galasko, et al.
Dementia and Geriatric Cognitive Disorders|January 9, 2016
Effect of Amyloid Imaging on the Diagnosis and Management of Patients with Cognitive Decline: Impact of Appropriate Use CriteriaMichael Grundman, Keith A Johnson, Ming Lu, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 22, 2015
Cognition in individuals at risk for Parkinson's: Parkinson associated risk syndrome (PARS) study findingsLama M Chahine, Daniel Weintraub, Keith A Hawkins, et al.
Journal of the International Neuropsychological Society : JINS|May 25, 2012
Everyday action impairment in Parkinson's disease dementiaTania Giovannetti, Priscilla Britnell, Laura Brennan, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 25, 2017
Cognition and the course of prodromal Parkinson's diseaseDaniel Weintraub, Lana M Chahine, Keith A Hawkins, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 26, 2005
Differences in [99mTc]TRODAT-1 SPECT binding to dopamine transporters in patients with multiple system atrophy and Parkinson's diseaseRandel L Swanson, Andrew B Newberg, Paul D Acton, et al.
Journal of Alzheimer'S Disease : JAD|March 8, 2021
Relationships Between Cognition and Neuropathological Tau in Alzheimer's Disease Assessed by 18F Flortaucipir PETMichael D Devous, Adam S Fleisher, Michael J Pontecorvo, et al.
Brain and Cognition|January 6, 2012
Sentence processing in Lewy body spectrum disorder: the role of working memoryRachel G Gross, Corey T McMillan, Keerthi Chandrasekaran, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 2, 2006
Rasagiline improves quality of life in patients with early Parkinson's diseaseKevin M Biglan, Steven Schwid, Shirley Eberly, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 21, 2012
Neuropsychologic assessment in collaborative Parkinson's disease research: a proposal from the National Institute of Neurological Disorders and Stroke Morris K. Udall Centers of Excellence for Parkinson's Disease Research at the University of Pennsylvania and the University of WashingtonG Stennis Watson, Brenna A Cholerton, Rachel G Gross, et al.
Pageof 19